New: Introducing the Finviz Crypto Map

Learn More

SunOpta's (NASDAQ:STKL) Q2 Sales Top Estimates, Stock Soars

By Max Juang | August 06, 2025, 8:03 PM

STKL Cover Image

Plant-based food and beverage company SunOpta (NASDAQ:STKL) reported Q2 CY2025 results exceeding the market’s revenue expectations, with sales up 12% year on year to $191.5 million. The company’s full-year revenue guidance of $810 million at the midpoint came in 1.5% above analysts’ estimates. Its non-GAAP profit of $0.04 per share was $0.02 above analysts’ consensus estimates.

Is now the time to buy SunOpta? Find out by accessing our full research report, it’s free.

SunOpta (STKL) Q2 CY2025 Highlights:

  • Revenue: $191.5 million vs analyst estimates of $185.7 million (12% year-on-year growth, 3.1% beat)
  • Adjusted EPS: $0.04 vs analyst estimates of $0.03 ($0.02 beat)
  • Adjusted EBITDA: $22.74 million vs analyst estimates of $22.54 million (11.9% margin, 0.9% beat)
  • The company lifted its revenue guidance for the full year to $810 million at the midpoint from $796.5 million, a 1.7% increase
  • EBITDA guidance for the full year is $101 million at the midpoint, in line with analyst expectations
  • Operating Margin: 5.5%, up from 1.5% in the same quarter last year
  • Free Cash Flow was -$9.21 million compared to -$15.28 million in the same quarter last year
  • Sales Volumes rose 14.4% year on year (26.9% in the same quarter last year)
  • Market Capitalization: $610 million

Company Overview

Committed to clean-label foods, SunOpta (NASDAQ:STKL) is a sustainability-focused food and beverage company specializing in the sourcing, processing, and packaging of organic products.

Revenue Growth

Examining a company’s long-term performance can provide clues about its quality. Any business can put up a good quarter or two, but the best consistently grow over the long haul.

With $763.2 million in revenue over the past 12 months, SunOpta is a small consumer staples company, which sometimes brings disadvantages compared to larger competitors benefiting from economies of scale and negotiating leverage with retailers.

As you can see below, SunOpta’s demand was weak over the last three years. Its sales fell by 4.9% annually despite consumers buying more of its products. We’ll explore what this means in the "Volume Growth" section.

SunOpta Quarterly Revenue

This quarter, SunOpta reported year-on-year revenue growth of 12%, and its $191.5 million of revenue exceeded Wall Street’s estimates by 3.1%.

Looking ahead, sell-side analysts expect revenue to grow 8.7% over the next 12 months, an acceleration versus the last three years. This projection is commendable and implies its newer products will spur better top-line performance.

Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.

Volume Growth

Revenue growth can be broken down into changes in price and volume (the number of units sold). While both are important, volume is the lifeblood of a successful staples business as there’s a ceiling to what consumers will pay for everyday goods; they can always trade down to non-branded products if the branded versions are too expensive.

SunOpta’s average quarterly volume growth of 16.3% over the last two years has beaten the competition by a long shot. This is great because companies with significant volume growth are needles in a haystack in the stable consumer staples sector.

SunOpta Year-On-Year Volume Growth

In SunOpta’s Q2 2025, sales volumes jumped 14.4% year on year. This result shows the business is staying on track, but the deceleration suggests growth is getting harder to come by.

Key Takeaways from SunOpta’s Q2 Results

We were impressed by how significantly SunOpta blew past analysts’ EPS expectations this quarter. We were also glad its revenue outperformed Wall Street’s estimates. On the other hand, its gross margin missed. Overall, we think this was a decent quarter with some key metrics above expectations. The stock traded up 7.1% to $5.55 immediately after reporting.

Sure, SunOpta had a solid quarter, but if we look at the bigger picture, is this stock a buy? The latest quarter does matter, but not nearly as much as longer-term fundamentals and valuation, when deciding if the stock is a buy. We cover that in our actionable full research report which you can read here, it’s free.

Mentioned In This Article

Latest News